To determine clinical and genomic characteristics and in-hospital mortality risk associated with acute kidney injury (AKI) in the multicenter prospective cohort of patients with blunt trauma. Summary Background Data: Less severe stages of AKI characterized by small changes in serum creatinine (sCr) are inadequately studied among trauma patients. Methods: We performed a secondary analysis of the "Inflammation and the Host Response to Injury" (Glue Grant) database to include adult blunt trauma patients without history of kidney disease. AKI was defined by the Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) classification, which requires a 50% increase in sCr and stratifies patients into following 3 severity stages: risk, injury, and failure. Association between all stages of AKI and in-hospital mortality was analyzed using a multivariable logistic regression analysis. Genome-wide expression analysis was performed on whole blood leukocytes obtained within 12 hours of trauma. Results: AKI occurred in 26% of 982 patients. The adjusted risk for hospital death was 3 times higher for patients with AKI compared with patients without AKI (odds ratio ϭ 3.05) (95% confidence interval, 1.73-5.40). This risk was evident in a dose-response manner and even patients with mild AKI had odds ratio for dying of 2.57 (95% confidence interval, 1.19 -5.50) compared with patients without AKI. Genome-wide expression analysis failed to show a significant number of genes whose expression could discriminate among patients with and without AKI. Conclusions: In a multicenter prospective cohort of blunt trauma patients, AKI characterized by small changes in sCr was associated with an independent risk of hospital death. (Ann Surg 2010;252: 158 -165) 
Objective:
To determine clinical and genomic characteristics and in-hospital mortality risk associated with acute kidney injury (AKI) in the multicenter prospective cohort of patients with blunt trauma. Summary Background Data: Less severe stages of AKI characterized by small changes in serum creatinine (sCr) are inadequately studied among trauma patients. Methods: We performed a secondary analysis of the "Inflammation and the Host Response to Injury" (Glue Grant) database to include adult blunt trauma patients without history of kidney disease. AKI was defined by the Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) classification, which requires a 50% increase in sCr and stratifies patients into following 3 severity stages: risk, injury, and failure. Association between all stages of AKI and in-hospital mortality was analyzed using a multivariable logistic regression analysis. Genome-wide expression analysis was performed on whole blood leukocytes obtained within 12 hours of trauma. Results: AKI occurred in 26% of 982 patients. The adjusted risk for hospital death was 3 times higher for patients with AKI compared with patients without AKI (odds ratio ϭ 3.05) (95% confidence interval, 1.73-5.40). This risk was evident in a dose-response manner and even patients with mild AKI had odds ratio for dying of 2.57 (95% confidence interval, 1.19 -5.50) compared with patients without AKI. Genome-wide expression analysis failed to show a significant number of genes whose expression could discriminate among patients with and without AKI. Conclusions: In a multicenter prospective cohort of blunt trauma patients, AKI characterized by small changes in sCr was associated with an independent risk of hospital death. A lthough acute kidney injury (AKI) is independently associated with adverse outcomes among critically ill patients, only a few studies have studied AKI among trauma patients. 1, 2 A majority of these studies have been retrospective, single center reports focusing on the severe AKI defined by the need for renal replacement therapy (RRT) or by an increase in serum creatinine (sCr) above a predefined, usually very high cut-off point. [3] [4] [5] [6] Although a few recent studies have reported the incidence for less severe AKI as high as 31%, 7, 8 the severe AKI defined by the need for RRT had a low incidence (between 0.1% and 8.4%) and high mortality (40%-70%). [3] [4] [5] Hence, the clinical importance of AKI with small changes in kidney function after trauma has not been adequately studied or appreciated in clinical practice.
With the recent introduction of the Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE), a new classification system for AKI, the adverse effects of small changes in sCr level have begun to be recognized, and the term "AKI" has been proposed to encompass the entire spectrum of the syndrome, from minor changes in renal function to the requirement for RRT, replacing the old term of "acute renal failure (ARF)." 9, 10 The RIFLE classification defines 3 grades of AKI severity (R-Risk, I-Injury, F-Failure) based on changes in sCr level relative to the baseline (Addendum Tables 1,  2 , online only, Supplementary Digital Content 1 and 2, available at: http:links.lww.com/SLA/A62). 11 No study to date has assessed RIFLE criteria among trauma patients.
Inflammation and the Host Response to Injury (Glue Grant) is a large-scale interdisciplinary research program funded by the National Institute of General Medical Sciences to uncover the biologic reasons for different clinical outcomes after traumatic injury. The Trauma-Related DataBase (TRDB), a large multicenter database containing deidentified, prospectively collected clinical and gene expression data from patients with severe blunt trauma, was developed as a part of this program and has greatly facilitated research of clinical outcomes after trauma. The goal of this study was to assess the incidence, clinical predictors, early genomic response of blood leukocytes, and the short-term mortality risk associated with RIFLEdefined AKI among patients with severe blunt trauma enrolled in the "Inflammation and the Host Response to Injury" study.
METHODS

Study Design
This study is a secondary analysis of the TRDB and comprises a multicenter prospective cohort of adult severe blunt trauma patients with no previous history of kidney disease. The Steering Committee of the Inflammation and the Host Response to Injury research program and the Institutional Review Board of the University of Florida approved our use of the database, in accordance with the federal requirements for access to protected patient information.
Subjects and Data Collection
Beginning November 2003, the Inflammation and the Host Response to Injury research program enrolled patients with severe blunt trauma in 8 participating Level I trauma centers (available at: www.gluegrant.org) (Addendum Table 3 , online only, Supplementary Digital Content 2, available at: http://links.lww.com/SLA/A63). We analyzed completed clinical data for patients older then 18 years (age range, 18 -90 years) who lived more than 24 hours after injury, and were enrolled between November 2003 and March 2008 (85 patients who died in the first 24 hours after injury were excluded). Although patients with a history of renal disease and sCr Ͼ2 mg/dL were excluded from enrollment, we also excluded additional 9 patients who had sCr Ͼ1.5 mg/dL and reported history of chronic kidney disease, as documented in the TRDB. The cohort that was selected for genomic analysis included a subset of these patients whose age was limited to Ͻ55 years and who lived longer then initial 24 hours after trauma (Addendum Table 4 , online only, Supplementary Digital Content 3, available at: http://links.lww.com/SLA/A64).
The Steering Committee of the collaborative research program developed standard operating procedures for clinical management of the patients to minimize variation across centers involved in the data collection. 12 As implemented, they were considered the standard of care for patient management and were mandated for all enrolled patients as well as for uniform routine care at each of the participating trauma centers. Trained nurse abstractors prospectively collected clinical data into TRDB, a web-based data collection platform adapted for this program. 13 
RIFLE-F N ‫؍‬ 68
Severity of illness (first 28 d) MOD max score (mean, 95% CI) 4.9 (4.7-5.1) 8.1 (3.4) 6.0 (5.5-6.5) 8.6 (7.9-9.2) 10.7 (10.0-11.4) Ͻ0.001 Ͻ0.001 MOD max-nonrenal score (mean, 95% CI) ‡ 4.1 (3.9-4.2) 6.4 (2.9) 4.9 (4.4-5.4) 7.0 (6.4-7.7) 7.9 (7.3-8.6) Ͻ0.001 Ͻ0.001 MOD max-nonrenal score Ն6, number (%) 146 (20) 141 (56) 
Outcomes and Covariate Definition
The Injury Severity Score (ISS) was used as a measure of anatomic injury severity. 14 Clinical outcomes occurring within 28 days of injury were recorded. We used definitions of nosocomial infections and surgical site infections recommended by the Centers for Disease Control. 15 The Marshall multiple organ dysfunction (MOD) score Ն4 was used as a cut-off point for an organ failure. 16 For each patient an Acute Physiology and Chronic Health Evaluation (APACHE II) score was calculated for the first 24 hours of injury. 17 In addition, we calculated APACHE II (no renal data) and MOD max-nonrenal scores by subtracting renal components from the total scores.
Assessment of AKI
AKI was defined by the RIFLE classification using the change in sCr during the first 28 days of hospitalization compared with baseline sCr (Addendum Tables 1, 2 , online only, Supplementary Digital Content 1, available at: http://links.lww.com/SLA/A62). 11 For the baseline sCr, we used the lower of 2 values as follows: the lowest measured sCr in the first 24 hours after trauma (85%, 832/982 patients) or the estimated sCr (Cr MDRD ) (15%, 150/982 patients). Cr MDRD was calculated by solving the abbreviated "Modification of diet in renal disease" (MDRD) equation for sCr assuming a glomerular filtration rate (GFR) of 75 mL/min/1.73 m 2 . 11 Patients with AKI were stratified according to the severity determined by comparing the highest sCr with the baseline sCr. RIFLE-R corresponds to a 50% increase in sCr, RIFLE-I to a 2-fold increase in sCr, and RIFLE-F to a 3-fold increase in sCr. Renal outcome was evaluated by comparing the last recorded sCr to the baseline sCr. Complete renal recovery existed if the sCr returned to a level less than 50% above baseline sCr. Partial renal recovery existed for a persistent increase more than 50% above baseline sCr but no need for RRT. No renal recovery implied a need for RRT at the time of hospital discharge or death.
Genomics Data Analysis
Microarray data from whole blood leukocytes for the initial 12 hours of injury were evaluated in a subset of the total trauma population. This subset differed from the total population in that the age distribution was 16 to 55 years. Microarray data from these patients were normalized using DNA Chip Analyzer 2007 (available at: http://www.dchip.org/). Only patients with complete data for RIFLE classification and RNA quality score greater than or equal to 2 were included. Unsupervised analyses were conducted by filtering for probe sets with greater than 50% coefficient of variation followed by hierarchical cluster analysis. BRB-ArrayTools (developed by Drs. Richard Simon and Amy Peng Lam, available at: http://linus.nci.nih.gov/BRB-ArrayTools.html) was used to perform significance analysis of microarray (SAM) comparisons between injured and healthy subjects and AKI versus no AKI patients. Class prediction models used F test (P Ͻ 0.001) to identify significant probe sets followed by Leave One Out Cross Validation (LOOCV) analysis using diagonal linear discriminate analysis, K nearest neighbors (for K ϭ 1 and 3), and nearest centroid prediction methods. All class comparisons and prediction models were carried out using 1000 permutations of the data set. Significance for SAM analysis was set using a false discovery rate of Ͻ0.001.
Statistical Analyses
Multivariate logistic models were used to assess factors associated with AKI and mortality during the hospitalization. Mul Age, sex, and race were excluded from the model as they are already included in the calculation of the ratio of the measured sCr in the first 24 hours and Cr MDRD . Components of Apache II (no renal data) score were included in the model as the score itself was not an important predictor in the model. The odds ratios were calculated with logistic regression analysis (methods). CI indicates confidence interval; OR, odds ratio; Cr MDRD , estimated serum creatinine for patient age, gender and race (methods); RBC, red blood cells; INR, international normalized ratio; FFP, fresh frozen plasma. univariate association with outcome (2-tailed P Յ 0.20) and then entered stepwise (backward and forward) into multivariable logistic models, with assessment of the association between AKI groups and outcome in the presence of the significant covariates. Each variable with a significant association (P Ͻ 0.05) and additional variables that were not significant but had potential clinical importance were included in the final full model. The goodness of fit of the logisticregression model was assessed with the Hosmer-Lemeshow test and c statistics evaluated the discriminatory capability of the models. Probit models were used to assess the estimated probability of any in-hospital AKI with specific parameters of interest occurring within 24 hours of hospitalization. Missing levels of parameters were considered missing at random (there were Ͻ10% missing values for the worse lactate levels in the first 24 hours while all other variables had Ͻ1% missing values) and were categorized as a separate level for the purposes of the analytic models. Sensitivity analyses confirmed that the primary study results were consistent with and without inclusion of these cases. All statistical tests for group comparisons were 2-tailed. Statistical analyses were performed with the SAS (version 9.2, Cary, NC). The authors had full access to the data and take responsibility for its integrity. All authors have read and agreed to the manuscript as written.
RESULTS
Incidence and Progression of AKI
We analyzed data for 982 adult patients with severe blunt trauma and no previous history of kidney disease who lived longer then 24 hours following injury (85 patients who died in the first 24 hours after injury were excluded) ( Table 1 and Addendum Tables  4, 5 , online only, Supplementary Digital Content, available at: http://links.lww/com/SLA/A64 and http://links.lww/com/SLA/A65). This cohort included severely injured patients as defined by inclusion criteria (82% of patients had ISS score Ն25, 80% had an episode of hypotension, and 60% required Ͼ6 units of blood transfusion in the first 24 hours of injury) ( Table 1 and Addendum  Table 4 , online only, Supplementary Digital Content, available at: http://links.lww.com/SLA/A64). Close to one-fourth of these patients developed AKI in the first 28 days after trauma (26%, 253/982) and Age, sex, and race were excluded from the model as they are already included in the calculation of Cr MDRD and RIFLE categories. Age is also included in the calculation of APACHE score. APACHE II and MOD scores were calculated without renal components to avoid correlation with AKI. The odds ratios were calculated with logistic regression analysis. CI indicates confidence interval; OR, odds ratio; RBC, red blood cells; FFP, fresh frozen plasma; MOD, multiple organ dysfunction.
two-third had only mild to moderately severe AKI (RIFLE-R and RIFLE-I) ( Table 2 and Addendum Table 4 , online only, Supplementary Digital Content, available at: http://links.lww.com/SLA/A64). The majority of the patients had the onset of AKI within the first 2 days of hospital admission (68%) and close to half of the patients progressed from RIFLE class R to RIFLE class I or class F (42%, 77/183). The time to progress from class R to class I was 2 (2, 5) days while time to progress to class F was 6 (3, 10) days. Only 11% of AKI patients required RRT. Almost half of the patients with AKI did not have complete recovery of their kidney function in the first 28 days after trauma. Increasing severity of AKI was associated with less likelihood of renal recovery ( Table 2 ).
Clinical Characteristics of Patients With AKI
Neither the baseline host factors nor anatomic ISSs were associated with the risk for AKI in a multiple logistic regression model that included multiple clinical parameters obtained during the first 24 hours of trauma (Table 3 ). In contrast, several indicators of physiologic injury severity including the lowest body temperature, the highest lactate level, and the need for packed red blood cells and cryoprecipitate transfusion were independently associated with a higher risk for developing AKI (Table 3 and Fig. 1 ). Interestingly, an absolute value of first measured sCr was not independently associated with the risk for AKI but rather the ratio between first measured sCr and estimated Cr MDRD based on patient's age, gender, and race (Methods) was independently associated with the risk for developing AKI. Every 10% increase in the ratio between measured sCr on admission and estimated Cr MDRD increased risk for developing AKI by 8%.
AKI and Clinical Outcomes After Trauma
Patients with AKI were more severely ill as reflected in the higher MOD scores ( Table 2) . Organ dysfunction as defined by MOD score Ն3 was more likely to occur among AKI patients and the occurrence of organ dysfunction was proportional to the severity of kidney injury. Notably, none of the patients with RIFLE-R and RIFLE-I and only half of the patients with RIFLE-F had kidney dysfunction on the basis of MOD score. Similarly, only 15% of all AKI patients would be classified as having posttraumatic acute renal failure using the American College of Surgeons Committee on Trauma definition (sCr above 3.5 mg/dL) and all of them were in the Rifle-F class. Even the American College of Surgeons National Surgical Quality Improvement project's definition of acute renal dysfunction as sCr above 2 mg/dL does not identify 55% of patients with Rifle-defined AKI ( Table 2) . Patients with AKI were more likely to develop both infectious and noninfectious complications. They required a longer ICU and hospital stay. The in-hospital mortality for patients with AKI was 30% in contrast to 5% for those with no AKI. 
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Acute Kidney Injury in Trauma Patients AKI was associated with a 3-fold increase in the risk for hospital mortality in the multivariate logistic model. This model also included host factors, anatomic and physiologic injury indicators in the first 24 hours after trauma, and severity scores. This increase in the risk for hospital mortality was proportional to the severity of AKI ( Table 4 ). The least severe yet the most frequent AKI (RIFLE-R) was associated with a 2.5-fold increase in the risk for mortality even after adjustment for the host characteristics, anatomic and physiologic injury indicators, and severity scores ( Table 4 ). The most severe AKI (RIFLE-F) was associated with a 5-fold risk for dying in hospital. In addition to AKI, ISS, and APACHE II scores on admission, use of vasopressors in the first 24 hours, and the highest MOD score in the first 28 days were independently associated with in-hospital mortality.
Genomics Analysis
The TRDB contained microarray data for 173 patients sampled within 12 hours of traumatic injury along with data obtained from 24 healthy uninjured subjects. Of the 173 trauma patients, 158 met inclusion criteria with 125 subjects having no AKI and 33 with AKI (13 RIFLE-R, 9 RIFLE-I, and 11 RIFLE-F) (detailed procedure is described in Addendum-"Genomic analysis," online only, Supplemental Digital Content 5-8, 1a, b, 2a, b, available at: http://links.lww.com/SLA/A66, http://links.lww.com/SLA/A67, http://links.lww.com/SLA/A68, and http://links.lww.com/SLA/A69). Class comparison and prediction between the 125 patients with no AKI and all 33 patients with AKI, identified 230 probe sets with a 68% to 77% correct classification rate (Supplements 3a, b, online only, Supplemental Digital Content 9 -10, available at: http://links.lww.com/SLA/A70 and http://links.lww.com/SLA/A71). Similarly, a multiclass comparison and prediction between injured patients without AKI and those with RIFLE classes R, I, and F, identified 151 probe sets with a 51% to 77% correct classification rate (Supplements 4a, b, online only, Supplemental Digital Content 11-12, available at: http://links.lww.com/SLA/A72 and http://links.lww.com/SLA/A73). When the 125 patients with no AKI were compared with the 11 patients in class RIFLE-F, 95 probe sets were identified that correctly classified the patients 85% to 91% of the time; however, the positive predictive value for patients with RIFLE-F was only 0.20 while patients with no AKI carried a positive predictive value of 0.93 (online only, Supplemental Digital Content 13-14, 5a, b, available at: http://links.lww.com/SLA/A74 and http://links.lww.com/SLA/A75). SAM analysis was used to verify the class comparison and prediction findings. However, analysis of patients with and without AKI, multiclass analysis between AKI and RIFLE classes, and injured patients with no AKI compared with RIFLE-F yielded no significant probe set differences. These findings suggest that although trauma patients with and without AKI may have different patterns of leukocyte gene expression, the genomic changes are modest and lack strong predictive properties. Such findings suggest that there do not appear to be strong genomic signatures associated with AKI in a severely injured cohort in which marked genomic changes are occurring after the injury.
DISCUSSION
In a multicenter prospective cohort study of trauma patients with no previous kidney disease, AKI was a common complication associated with an independent risk of hospital death. Close to one-fourth of all trauma patients developed AKI and two-third of them had only mild to moderately severe AKI. Even patients with the least severe AKI had a 2.5-fold increase in adjusted risk for death compared with patients without AKI. This risk was independent of other indicators of anatomic and physiologic injury severity, and other organ dysfunction. Although the likelihood of developing AKI was associated with changes in several clinical parameters in the first 24 hours after trauma, no such association was observed with the initial genomic characteristics of patients with AKI.
Although the adverse effect of all stages of severity of AKI on in-hospital mortality is increasingly recognized, 9 few studies have examined the impact of less severe AKI among trauma patients. 3-5,7,8,18 -20 The American College of Surgeons Committee on Trauma defines acute renal failure after trauma as sCr above 3.5 mg/dL, but only 15% of the AKI patients in our study had a sCr greater than 3 mg/dL. The average highest sCr among patients with mild AKI was 1.33 mg/dL, a value that often doesn't attract clinical attention in a population of younger trauma patients. 6 At the same time, none of the patients with mild and moderate AKI had a renal Marshall score greater or equal to 4, and consequently would not be classified as having kidney dysfunction by using this traditional scoring system. 16 Hence, the importance of small changes in sCr early after trauma, indicative of less severe AKI, is likely to be under appreciated and adequate follow-up for these patients may not occur in a timely manner. On the other hand, early diagnosis of AKI may help to identify high-risk patients who would benefit from implementation of goal-directed resuscitation therapy, a strategy proven to work for patients with severe sepsis. 21 Our findings reiterate the importance of relative changes in sCr rather than absolute sCr value in determining the risk for the development of AKI because no single sCr value corresponds to a given GFR across all patients. Instead the change in sCr compared with baseline determines AKI. 11 To estimate baseline renal function when sCr is unknown, RIFLE advocates use of estimated Cr MDRD for the GFR of 75 mL/min per 1.73, a lower end of the normal range for healthy individuals. 22 This relative increase in first measured sCr compared with estimated Cr MDRD was an independent risk factor for the development of AKI in a multivariate model where every 10% increase in measured sCr increases the risk for AKI by 8%. Hence, in clinical practice, an assessment of the relative increase between the first measured sCr and estimated Cr MDRD may offer a valuable prognostic tool for the risk of AKI.
We demonstrated that less severe AKI was not only common among trauma patients but also associated with adverse clinical outcomes. Even the mild AKI was associated with a 2.5-fold increase in the risk of dying in a multivariate regression model that included baseline clinical characteristics, indicators of anatomic and physiologic injury severity in the first 24 hours, the severity of other organ dysfunction and details of early resuscitation. All these parameters carry clinical significance and the results are easily generalized for physicians caring for trauma patients. Although many of the covariates have been previously shown to be associated with in-hospital mortality [23] [24] [25] the association of each stage of AKI with increased in-hospital mortality is demonstrated for the first time in this study. Future studies should focus on identifying patients at the highest risk for death even earlier, preferably within the first 12 to 24 hours after trauma.
The failure to identify any significant differences in blood leukocyte expression between patients with and without AKI is not surprising. Compared with healthy controls, trauma induced a genomewide reprioritization of leukocyte gene expression, with greater than 60% of the leukocyte transcriptome changing within the first 12 hours. These changes were comparable to or greater than the changes seen after administration of microbial products to healthy volunteers. 26 We found only modest differences in genome-wide expression in the trauma patients who experienced AKI, regardless of the RIFLE score. This lack of difference may reflect the overall genomic response to the severity of the traumatic injury, rather than as a predictor for the differential physiological responses leading to AKI.
AKI should no longer be viewed as an indicator of overall severity of illness but instead the injured kidney can exhibit inde-pendent effects on other organs, including lungs. [27] [28] [29] The kidneys receive a higher blood flow per unit mass than other organs but the fraction of extracted oxygen is low due to the presence of abundant diffusional arterial-to-venous shunting in the cortex and medulla. 30 This arterial-to-venous shunting accounts for up to 50% of the oxygen removal from arterial blood before the glomerular capillaries, rendering the kidney very sensitive to conditions of hypoperfusion. 30 During experimental hemorrhagic shock, the oxygenation status in kidneys may be impaired in spite of the preserved blood flow. 31 At the same time, hypoxia may limit renal use of lactate for anaerobic metabolism. 32 The oxygen supply to the renal tissue may become impaired even earlier during acute normovolemic hemodilution, such as during resuscitation with large quantities of crystalloid solutions after trauma. 33 Once initiated, AKI incites a cascade of inflammatory processes both locally and systemically. 34 Because of this susceptibility for hypoxia and early development of kidney injury, the use of more sensitive markers of kidney injury after trauma may be a useful tool for identifying patients at risk for AKI as well as other organ dysfunctions and dying.
Our study has several limitations. This is a retrospective analysis of prospectively collected data from which causal inference cannot be derived and which is subject to bias from unmeasured factors. Although we attempted to control for selection bias with multivariate statistical method and risk adjustment, we could not completely eliminate the potential for residual confounding. Second, we did not have access to information related to survival after hospital discharge; therefore, our risk estimates for discharged patients might represent the lower limit of the true risk. Finally, our analysis addressed the relationship between all-cause sCr increase and subsequent adverse events. The etiology of AKI after trauma is usually multifactorial and the strong association of even mild AKI with hospital mortality was demonstrated regardless of the etiology of AKI. 9 No conclusive data exist to demonstrate that 2 traditional etiological categories of AKI, prerenal azotemia, and acute tubular necrosis, have meaningful prognostic differences, or, despite common clinical practice, differing rates of response to therapy. 35 A recent report from the AKI Network has favored the concept of volume-responsive AKI, and they have suggested a research agenda to address the clinical significance of this type of AKI in future studies. 36 In conclusion, in a large multicenter prospective cohort of trauma patients with no previous kidney disease, AKI was associated with an independent risk of hospital death. This risk was evident in a dose-response manner and even patients with the mild AKI had a 2.5-fold increase in adjusted risk for death compared with patients without AKI. Future studies need to address whether early identification of patients with less severe AKI will provide a window for therapeutic interventions that may reverse adverse clinical outcomes.
